on 07 Dec 2021
Last Applicant/ Owned by
44 Whippany Road, Suite 280
Morristown
NJ
07960
Serial Number
87935592 filed on 24th May 2018
Registration Number
6583832 registered on 07th Dec 2021
Correspondent Address
Daniel D. Frohling
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"(ORITAVANCIN)"
"(ORITAVANCIN)" Color is not claimed as a feature of the mark. pharmaceutical preparations, namely, anti-infective preparations and substances containing oritavancin In the statement, line 1 should be deleted, and Melinta Therapeutics, LLC (Delaware limited liability company) should be inserted. The mark consists of the word "ORBACTIV" in bold large lettering and underneath is the word "(ORITARead More
pharmaceutical preparations, namely, anti-infective preparations and substances containing oritavancin
29th Jun 2018
29th Jun 2018
No 87935592
No Service/Collective Mark
No 231087-00049
No
No
No
No
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.18 -
Three or more concentric circles
26.01.21 -
Circles that are totally or partially shaded
26.01.26 -
Spirals, coils and swirls
The mark consists of the word "ORBACTIV" in bold large lettering and underneath is the word "(ORITAVANCIN)" in less bold, slightly smaller lettering. To the left is a series of curved lines forming an open spiral design with a dot on the top right of the outermost curved line.
| Status Date | Action Taken |
|---|---|
| 11th May 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 11th May 2022 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 22nd Dec 2021 | TEAS SECTION 7 REQUEST RECEIVED |
| 07th Dec 2021 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Nov 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Nov 2021 | ASSIGNED TO EXAMINER |
| 02th Nov 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th Oct 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Oct 2021 | SOU EXTENSION 5 GRANTED |
| 18th Oct 2021 | STATEMENT OF USE PROCESSING COMPLETE |
